Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy

Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction

(2021) Rebecca J. Woolley et al.   EUROPEAN JOURNAL OF HEART FAILURE

Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy

(2021) Yuichi J. Shimada et al.   Circulation-Heart Failure

Variable and limited predictive value of the European Society of Cardiology hypertrophic cardiomyopathy sudden death risk model: a meta-analysis

(2019) Jie Wang et al.   CANADIAN JOURNAL OF CARDIOLOGY

Identification of a Multiplex Biomarker Panel for Hypertrophic Cardiomyopathy using Quantitative Proteomics and Machine Learning

(2019) Gabriella Captur et al.   MOLECULAR & CELLULAR PROTEOMICS

Application of Proteomics Profiling for Biomarker Discovery in Hypertrophic Cardiomyopathy

(2019) Yuichi J. Shimada et al.   Journal of Cardiovascular Translational Research

Proteomics in cardiovascular diseases: Unveiling sex and gender differences in the era of precision medicine

(2018) Roberta Baetta et al.   Journal of Proteomics

Artificial Intelligence in Cardiology

(2018) Kipp W. Johnson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: Potential for refinement of current criteria

(2018) Milind Y. Desai et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Three-dimensional Epigenome Statistical Model: Genome-wide Chromatin Looping Prediction

(2018) Ziad Al Bkhetan et al.   Scientific Reports

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy

(2018) Carolyn Y. Ho et al.   CIRCULATION

Novel endotypes in heart failure: effects on guideline-directed medical therapy

(2018) J Tromp et al.   EUROPEAN HEART JOURNAL

STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

(2018) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy PatientsCLINICAL PERSPECTIVE

(2017) Allison L. Cirino et al.   Circulation-Cardiovascular Genetics

Increased Transforming Growth Factor-β Levels Associated With Cardiac Adverse Events in Hypertrophic Cardiomyopathy

(2015) Burak Ayça et al.   CLINICAL CARDIOLOGY

Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy

(2015) Lu Fang et al.   Journal of Translational Medicine

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

(2013) C. O'Mahony et al.   EUROPEAN HEART JOURNAL

Effects of Losartan on Left Ventricular Hypertrophy and Fibrosis in Patients With Nonobstructive Hypertrophic Cardiomyopathy

(2013) Yuichi J. Shimada et al.   JACC-Heart Failure

MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1L613V mutation

(2011) Xue Wu et al.   JOURNAL OF CLINICAL INVESTIGATION

Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β

(2010) Polakit Teekakirikul et al.   JOURNAL OF CLINICAL INVESTIGATION

Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy

(2010) Carolyn Y. Ho et al.   NEW ENGLAND JOURNAL OF MEDICINE

Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back

(2009) Katherine A. Rauen et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A